A Biopharmaceutical and Wellness Company

Committed to quality products, brands and services for the global cannabinoid marketplace


TerrAscend is a biopharmaceutical and wellness company that is committed to quality products, brands, and services for the global cannabinoid market. The Company participates in the medical and legal adult-use market in Canada and in US states where cannabis has been legalized for therapeutic or adult-use. TerrAscend operates a number of synergistic businesses, including Arise Bioscience Inc., a manufacturer and distributor of hemp-derived products, Ascendant Laboratories Inc., a biotechnology and licensing Company committed to the continuous improvement of cannabinoid expressing plants, and Solace RX Inc., a proposed drug preparation premises focused on the development of novel formulations and dosage forms.




TerrAscend Canada Inc., a licensed cannabis producer under the Cannabis Act, provides medical cannabis to patients through its online medical marketplace Solace Health.

TerrAscend Canada Inc. also participates in the adult-use market in Canada through direct and indirect supply agreements in several provinces.



Solace Health Network is a network of support programs for patients and healthcare practitioners seeking medical cannabis treatment, education, and coverage.

SHN supports each patient from initial contact through to verified medical authorization, helping to maneuver through barriers and reduce any confusion along the way.

Solace Health Network leverages a wealth of knowledge from the pharmaceutical industry and a vast network of allied health professionals to provide uncomplicated medical cannabis access to patients across Canada.



Solace Health is the Online Marketplace for Licensed Producer, TerrAscend Canada Inc. Solace Health provides patients a unique one-stop-shop for all of their medical cannabis product and accessory needs. Solace Health aims to be the choice of patients through its friendly and convenient on-boarding and shopping experience.

Solace Health provides same-day home delivery in the GTA, support for Veteran patients, and Compassionate Care Pricing. Whether it is finding the right product for your needs or help on how to consume, Solace Health is here to provide assistance at your finger tips.


Our industry’s first Drug Preparation Premises (DPP) facility will allow TerrAscend the ability to innovate and produce specialized pharmaceutical products for healthcare professionals and institutions. Solace Rx will deliver formulations that will address unmet medical needs where no commercial product is otherwise available.

Solace Rx further positions TerrAscend as a leading medical cannabis company in the field of personalized medicine. Operations of Solace Rx are scheduled to launch in 2019. For more information, contact Mike Hannalah, President & Co-Founder, at info@solacerx.com.



Haven St.

Premium Cannabis

Invented by the innovative, crafted by the curious, and expanded by the explorers. Here, every door leads to experience and discovery waits around every corner.

Find inner peace. Reset your soul. Focus your mind. Escape to slumber. Rise to unbelievable sensation. Each block on Haven St. is a new experience to discover, and every address delivers a new variation.

Whoever you are, wherever you’re going, Haven St. can take you there. Explore Responsibly.

Must be of legal age to consume our products.


Knüba Naturals

Knüba Naturals is a line of premium cannabis products, cultivated by a team of passionate growers. We believe everyone deserves a good quality of life and aims to enhance general well-being through the power of cannabis.

Knüba Naturals strives to deliver new cannabis products and formulations to meet a variety of patient needs and enhance patient outcomes.


Built to GMP requirements


67,300 sq ft facility strategically located in Mississauga


Premium hydroponic cultivation


Sterile & non-sterile drug compounding capabilities


Lab tested to the highest standards


Press Releases & News

Contact Investor Relations




Hello! We want to learn about your business, discuss your need for investment and explore opportunities to work together.  Please share your non-confidential information on the form below and we’ll be in touch.


Executive Leadership Team

Michael Nashat — CEO

Michael Nashat has over 12 years of experience in patient care, quality assurance, medical and regulatory affairs and R&D. Prior to joining TerrAscend, Mr. Nashat was the Executive Director of OnPharm Independent Pharmacy Group, which represents over 300 pharmacies. A former board member of Ontario College of Pharmacists, Canadian Association of Chain Drug Stores and the Ontario Ministry of Health and Long-Term Care’s Pharmacy Council.

Matthew Johnson — President

Matthew Johnson, a seasoned healthcare industry executive with over 25 years of experience, has held multiple senior-level positions with several large medical device and pharmaceutical companies. Most recently, he led the AbbVie Transition Office and was responsible for managing enterprise-wide transformation efforts, including merger integration. Prior to this, he headed Global Alliance Management within Abbott’s pharmaceuticals division where he drove collaboration strategy planning, alignment and communication among project teams for all of Abbott’s partnered pipeline products. He also held senior leadership roles at Brunswick Corporation and Baxter Healthcare Corporation.

Adam Kozak — Chief Financial Officer

Adam Kozak recently joined TerrAscend as Chief Financial Officer. He brings with him a wealth of experience from Loblaw Companies Limited.  During his 10-year tenure, Adam led initiatives in mergers and integration, process re-engineering and analytics. Prior to Loblaw, Adam also held positions at Deloitte and Wormald Masse Keen Lopinski.

Business Team

Robyn Rabinovich — Vice President, Business Strategy

Robyn Rabinovich is a business development professional with extensive experience in the cannabis space. Her knowledge supports her ability to evaluate business development opportunities within Canada and across the globe. Robyn obtained her International Business Degree from Dalhousie University.

Ari Unterman — Vice President, Business Development

Ari Unterman was formerly a corporate lawyer with experience in corporate and technology law. He has also participated in entrepreneurial and start up ventures, including supporting an early stage legal technology start up. Ari obtained his BA in Political Science at Western University and his JD/MBA at the University of Windsor.

Board of Directors

Jason Wild — Chairman

Jason Wild is the President and Chief Investment Officer of JW Asset Management, LLC. Mr. Wild received his license as a pharmacist in 1997, and subsequently founded JW Asset Management, LLC in 1998. The firm has a strong history of finding opportunities within the specialty pharmaceutical sector. He is a graduate of the Arnold and Marie Schwartz College of Pharmacy where he received a bachelor’s degree in Pharmacy.

Michael Nashat — CEO

Michael Nashat has over 12 years of experience in patient care, quality assurance, medical and regulatory affairs and R&D. Prior to joining TerrAscend, Mr. Nashat was the Executive Director of OnPharm Independent Pharmacy Group, which represents over 300 pharmacies. A former board member of Ontario College of Pharmacists, Canadian Association of Chain Drug Stores and the Ontario Ministry of Health and Long-Term Care’s Pharmacy Council.

Richard Mavrinac — Director

Richard Mavrinac held positions as CFO for George Weston Limited and Executive VP of Loblaw Companies and has extensive expertise in public company finance and strategy.

Dr. Gopal Bhatnagar — Director

Gopal Bhatnagar is the co-founder of one of the largest e-cigarette suppliers and retailers in Canada, 180° Smoke and is an Adjunct Assistant Professor of Surgery at University of Toronto. He is the former Chief of Staff and former Head of the Cardiovascular Surgery Unit at Trillium Hospital. He currently serves as Head of the Cardiac Surgery Division at Cleveland Clinic, Abu Dhabi.

Craig Collard — Director

Craig Collard is the CEO of Veloxis Pharmaceuticals, a commercial-stage specialty pharmaceutical company committed to improving the lives of transplant patient and has over 20 years of experience in the pharmaceutical industry. Mr. Collard has a proven track-record of leadership, managing organizational change, and driving successful merger and acquisition activity. Prior to Veloxis, Mr. Collard was the Founder and CEO of Cornerstone Therapeutics, a company focused on hospital, respiratory and adjacent specialty markets.



We’re growing fast and looking for top talent to join our team. Click on a link below to submit your application.


Stay tuned for updates and news